Tags

Type your tag names separated by a space and hit enter

AD2000: donepezil in Alzheimer's disease.
Lancet. 2004 Jun 26; 363(9427):2100-1.Lct

Authors+Show Affiliations

Schneider LS
Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. lschneid@usc.edu

MeSH

Activities of Daily LivingAlzheimer DiseaseCholinesterase InhibitorsCognitionCost-Benefit AnalysisDonepezilDrug IndustryHumansIndansNootropic AgentsPiperidinesRandomized Controlled Trials as TopicTreatment Outcome

Pub Type(s)

Journal Article
Comment

Language

eng

PubMed ID

15220027

Citation

Schneider, Lon S.. "AD2000: Donepezil in Alzheimer's Disease." Lancet (London, England), vol. 363, no. 9427, 2004, pp. 2100-1.
Schneider LS. AD2000: donepezil in Alzheimer's disease. Lancet. 2004;363(9427):2100-1.
Schneider, L. S. (2004). AD2000: donepezil in Alzheimer's disease. Lancet (London, England), 363(9427), 2100-1.
Schneider LS. AD2000: Donepezil in Alzheimer's Disease. Lancet. 2004 Jun 26;363(9427):2100-1. PubMed PMID: 15220027.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - AD2000: donepezil in Alzheimer's disease. A1 - Schneider,Lon S, PY - 2004/6/29/pubmed PY - 2004/7/14/medline PY - 2004/6/29/entrez SP - 2100 EP - 1 JF - Lancet (London, England) JO - Lancet VL - 363 IS - 9427 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/15220027/AD2000:_donepezil_in_Alzheimer's_disease_ DB - PRIME DP - Unbound Medicine ER -